Radiation Therapy Oncology Group Rtog 0625 a Randomized Phase Ii Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Year: 2009
Type: article
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2554303722
